Immunosuppressive blood cells and methods of producing the same

US11123368B2 · kind B2 · utility

Assignee

• UNIVERSITÄTSKLINIKUM HEIDELBERG · DE

Inventors

• Peter Terness · Eppelheim, DE
• Gerhard Opelz · Heidelberg, DE
• Helmut Simon · Dielheim, DE
• Sandra Ehser · Mauer, DE
• Christian Kleist · Neckargemünd, DE
• Flavius Sandra-Petrescu · Karlsruhe, DE
• Mircea Iancu · Mannheim, DE
• Lucian Jiga · Oldenburg, DE
• Jing-Jing Chuang · Tainan, TW
• Thilo Oelert · Heidelberg, DE

Key dates

• Filing date: May 19, 2017
• Grant date: Sep 21, 2021
• Expiry date: May 19, 2037

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N2501/06
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention refers to a method of producing immunosuppressive bleed cells that can be used for the treatment of autoimmune diseases, in particular multiple sclerosis, organ graft rejection and graft-versus-host disease.